Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
10 hedge funds and large institutions have $1.62M invested in Orgenesis Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
711% more capital invested
Capital invested by funds: $200K → $1.62M (+$1.42M)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
| 2 |
BlackRock
New York
|
+$178K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$56.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$7.99K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.99K |
| 4 |
SP
SWS Partners
Columbus,
Ohio
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.25M | +$1.35M | +14,482 | New |
|
|
2
BlackRock
New York
| $166K | +$178K | +1,917 | New |
|
|
PAM
3
Panagora Asset Management
Boston,
Massachusetts
| $93K | +$56.3K | +606 | +131% |
|
4
Morgan Stanley
New York
| $88K | – | – | – |
|
5
Citigroup
New York
| $11K | – | – | – |
|
|
WEC
6
Winslow Evans & Crocker
Boston,
Massachusetts
| $10K | – | – | – |
|
|
7
Bank of America
Charlotte,
North Carolina
| $2K | -$7.99K | -86 | -81% |
|
|
SFG
8
SevenBridge Financial Group
Harrisburg,
Pennsylvania
| $2K | – | – | – |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$5K | -50 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$3.99K | -43 | -88% |
|
|
SP
11
SWS Partners
Columbus,
Ohio
| – | -$1K | -12 | Closed |
|
ORGS Hedge Fund Activity: Q2 2018 in Review
10 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2018, worth a combined $1.62M — up 711% from $200K a quarter earlier.
Fund positioning in ORGS was balanced in Q2 2018: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $1.35M. The largest seller was Bank of America, cutting an estimated $7.99K.
- 10 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $1.62M of Orgenesis Inc. Common Stock stock for Q2 2018, up 711% quarter-over-quarter.
- 2 funds opened new Orgenesis Inc. Common Stock positions in Q2 2018 and 2 closed out, a net change of 0 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q2 2018 was Vanguard Group, an estimated $1.35M added.
- The largest Orgenesis Inc. Common Stock seller in Q2 2018 was Bank of America, an estimated $7.99K sold.
Based on aggregated 13F filings for Q2 2018.